Perino, Alessia http://orcid.org/0000-0002-5434-3266
Velázquez-Villegas, Laura. A. http://orcid.org/0000-0002-5310-5637
Bresciani, Nadia
Sun, Yu
Huang, Qingyao http://orcid.org/0000-0002-8255-4722
Fénelon, Valérie S. http://orcid.org/0000-0001-8023-0049
Castellanos-Jankiewicz, Ashley
Zizzari, Philippe http://orcid.org/0000-0001-8838-0762
Bruschetta, Giuseppe
Jin, Sungho
Baleisyte, Aiste http://orcid.org/0000-0003-3532-1368
Gioiello, Antimo http://orcid.org/0000-0003-0240-2006
Pellicciari, Roberto
Ivanisevic, Julijana
Schneider, Bernard L.
Diano, Sabrina
Cota, Daniela http://orcid.org/0000-0002-6909-2156
Schoonjans, Kristina http://orcid.org/0000-0003-1247-4265
Funding for this research was provided by:
AXA Research Fund
U.S. Department of Health & Human Services | NIH | Center for Information Technology (DK097566)
Agence Nationale de la Recherche (ANR-17-CE14-0007, ANR-10-EQX-008-1 OPTOPATH)
Institut National de la Santé et de la Recherche Médicale
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_189178, CRSII5_180317/1)
École Polytechnique Fédérale de Lausanne
Stiftelsen Kristian Gerhard Jebsen
Article History
Received: 13 September 2020
Accepted: 26 April 2021
First Online: 24 May 2021
Competing interests
: A.G. and R.P. are cofounders of TES Pharma. R.P. is the president and CEO of TES Pharma. The other authors declare no competing interests.